Induction of labour with mifepristone after intrauterine fetal death. 1985

D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004963 Estrenes Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. 19-Norandrostenes,19 Norandrostenes
D005260 Female Females
D005313 Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000019 Abortifacient Agents Chemical substances that interrupt pregnancy after implantation. Abortifacient Effect,Abortifacient Effects,Abortifacients,Contraceptive Agents, Postconception,Agents, Abortifacient,Agents, Postconception Contraceptive,Effect, Abortifacient,Effects, Abortifacient,Postconception Contraceptive Agents
D000021 Abortifacient Agents, Steroidal Steroidal compounds with abortifacient activity. Steroid Abortifacients,Abortifacients, Steroid,Agents, Steroidal Abortifacient,Steroidal Abortifacient Agents
D000032 Abortion, Therapeutic Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed) Therapeutic Abortion,Abortions, Therapeutic,Therapeutic Abortions
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015735 Mifepristone A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME. Mifegyne,Mifeprex,Mifégyne,R-38486,R38486,RU-38486,RU-486,ZK-98296,ZK98296,R 38486,RU 38486,RU 486,RU38486,RU486,ZK 98296

Related Publications

D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
August 1990, American journal of obstetrics and gynecology,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
October 2023, Mymensingh medical journal : MMJ,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
September 2012, Archives of gynecology and obstetrics,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
March 1978, Prostaglandins,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
January 2007, Acta obstetricia et gynecologica Scandinavica,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
March 1972, The Journal of obstetrics and gynaecology of the British Commonwealth,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
October 1964, Obstetrics and gynecology,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
April 1965, The Journal of the Oklahoma State Medical Association,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
June 1994, British journal of obstetrics and gynaecology,
D Cabrol, and M Bouvier D'Yvoire, and E Mermet, and L Cedard, and C Sureau, and E E Baulieu
January 2000, The Cochrane database of systematic reviews,
Copied contents to your clipboard!